AD101
/ Shenzhen 01 Life Science and Technology
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 30, 2019
Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=52 | Completed | Sponsor: Addpharma Inc. | Recruiting ➔ Completed
Trial completion • Osteoporosis • Rheumatology
December 05, 2018
Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=52 | Recruiting | Sponsor: Addpharma Inc.
New P1 trial • Osteoporosis • Rheumatology
1 to 2
Of
2
Go to page
1